Next Article in Journal
Hepatitis E Virus (HEV) Infection in the Context of the One Health Approach: A Systematic Review
Previous Article in Journal
Retrospective Review of Children Hospitalized for Epstein–Barr Virus-Related Infectious Mononucleosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Fatal Paraclostridium sordellii Infection: Post-Mortem Assessment and Review of the Literature

1
Forensic Medical Sciences, Department of Health Science, University of Florence, 50100 Florence, Italy
2
Pathological Anatomy Unit, Careggi University Hospital, 50100 Florence, Italy
3
Microbiology and Virology Unit, Careggi University Hospital, 50100 Florence, Italy
4
Department of Advanced Biomedical Sciences—Legal Medicine Section, University of Naples “Federico II”, 80100 Naples, Italy
5
Department of Experimental and Clinical Medicine, University of Florence, 50100 Florence, Italy
*
Author to whom correspondence should be addressed.
Pathogens 2025, 14(7), 703; https://doi.org/10.3390/pathogens14070703
Submission received: 5 May 2025 / Revised: 6 July 2025 / Accepted: 14 July 2025 / Published: 16 July 2025

Abstract

Clostridium sordellii, which has recently been reclassified as Paeniclostridium sordellii and subsequently as Paraclostridium sordellii, is a rare human pathogen linked to infections of high morbidity and mortality, often presenting as fulminant toxic shock syndrome. Although most documented cases involve individuals with pre-existing health issues, such as immunosuppression and cancer, or those who have undergone specific gynecological procedures, there are few instances reported in otherwise healthy individuals. In this report, we present a case of fatality associated with P. sordellii infection in a young individual with a history of drug abuse, following post-mortem examinations. Additionally, we provide an updated review of the latest literature on this topic.

1. Introduction

Clostridium sordellii (recently renamed Paeniclostridium sordellii [1] and then Paraclostridium sordellii [2]) is an infrequent human pathogen associated with infections of high morbidity and mortality, possibly presenting as fulminant toxic shock syndrome. While most cases have been described in subjects with underlying conditions, including immunodepression [3] and oncological disease [4,5,6,7,8,9,10], or after specific gynecological procedures [11,12,13,14,15,16,17,18,19], few cases were reported among previously healthy subjects, mostly related to recent injury [20,21,22,23] or acute omphalitis in newborns [24,25,26,27,28]. A small number of cases is related to injection drug use [10,29,30,31], especially black tar heroin [32,33]. The largest review was performed by Aldape et al. in 2006 [34].
Here, we report on a case of death associated with P. sordellii infection in a young drug abuser, diagnosed by post-mortem microbiological investigations.

2. Case Presentation

Early in the morning on a cold winter’s day, a forty-year-old woman was discovered in a public park attended by drug users and other related individuals. She was warmly dressed due to the cold temperature, estimated between 9.1 and 11.7 degrees Celsius according to the weather service. She was found unconscious and unresponsive in her makeshift shelter by a groundskeeper. Medical assistance was called, and the first physician to arrive witnessed the woman’s death without attempting any resuscitative maneuvers. The physician noted that the body showed abundant hypostasis, consistent with the described position (the body was faced down). No traumatic lesions or venipunctures were detected. The woman tested positive for drug abuse on her medical history, which included intravenous heroin use dating back to her youth and, more recently, smoking crack cocaine.
Despite multiple hospitalizations and support from specific local centers in the rehabilitation community, all attempts at rehabilitation failed. Although the woman had stopped using needles, she continued to smoke crack, as recently documented. In the days preceding the discovery of her body, she showed no signs of illness and had not reported feeling unwell (the last contact with the rehab community occurred less than 24 h before her death).
The body was taken to the local Forensic Medicine Institute and stored (in supine position) in a mortuary refrigerator set to a constant temperature of 0–4 degrees Celsius until the autopsy, which was performed 72 h after the discovery.
  • Autopsy findings
An autopsy was conducted on the body, including a thorough external and internal post-mortem examination. During the external examination, the pathologist noted complete hypostasis migration, rigor mortis fully set in—although easily reversible—and a small area of greenish discoloration, measuring approximately 3 × 2 cm, in the upper left abdomen.
No traumatic injuries were found, but a reddish fluid was seen leaking from the nostrils. There were no venipunctures.
Upon dissecting the head, the pathologist found a moderately edematous brain with consistent texture. The abdominal and thoracic organs appeared deteriorated, showing changes in color and texture and smelled sickeningly sweet odor. The lungs were congested and edematous, the heart had no significant abnormalities, and the liver was enlarged and structurally altered, with microvesicular steatosis and fibrosis and steatohepatitis. The intestines were distended with gas, but no mucosal changes were detected.
During the autopsy, organ samples were taken for histological examination, biological fluids were collected for toxicological analysis, and samples and swabs were obtained for microbiological testing as per the Forensic Unit’s internal protocol.
  • Histological findings
Multiple organ samples were taken from the lungs, brain, heart, kidneys, spleen, pancreas, and liver. They were included in paraffin and cut with a microtome into micrometric slides. Hematoxylin and eosin staining was performed, and specimens were observed under a microscope (Figure 1).
Histological examination revealed multi-visceral congestion, brain edema, lung edema, areas of cardiac necrosis with edema, and hepatic steatosis. In all parenchymas, congestion and the presence of lymphocytic and granulocytic infiltrates were found. Copious intravascular granulocytes and a lesser number of lymphocytes were also observed at the intravascular site. Gram-positive bacilli were widespread in the heart, lung, and kidney (Gram staining) (Figure 2). Immunohistochemical testing of tissues was conducted to disclose the inflammatory response and leukocytes cells. In particular, antibodies for CD15 (MMA) ® and CD68 (PG-M1) ® were obtained from Diagnostic BioSystems (DBS) (Pleasanton, CA, USA).

3. Results

  • Post-mortem microbiological investigations
Microbiological cultures were carried out on specimens collected post-mortem, including blood, urine, rectal swabs, pharyngeal swabs, and samples from heart, brain, lung (right and left anterior upper lobe, right and left anterior lower lobe and right medial anterior lobe), kidneys (right and left), liver and spleen.
Blood, urine and mucosal swabs were taken during the external examination, by puncture of the femoral artery, suprapubic puncture, and direct swabbing, respectively. Tissue samples were taken during autopsy. Before sampling of blood and urine, the skin was carefully disinfected with betadine and sterile test vials and needles were used.
Blood was directly inoculated in 4 blood culture vials for aerobic and anaerobic cultures (BactAlert system, Marcy l’Etoile, France, bioMérieux). Urine was collected in a sterile tube and then transferred to a urine SpongeTM (Copan, Murrieta, CA, USA) according to the manufacturer’s instructions. FecalSwabTM and UTMTM transport media (Copan, Murrieta, CA, USA) were used for rectal and pharyngeal swabs, respectively. Other samples (1–2 cm3) were collected in sterile tubes containing minimal amount (0.5 mL) of sterile normal saline to preserve from drying out. All specimens were transferred to the laboratory and processed within 1 h. Culture media, incubation conditions and incubation times are reported in Table S1.
Bacterial identification was carried out by MALDI-ToF mass spectrometry (MALDI Biotyper® Bruker Daltonics, Bremen, Germany). Identification of P. sordellii was further confirmed by a whole-genome sequencing (WGS)-based analysis of one isolate, using the TYGS server [35]. Table 1 shows, for each sample, which bacteria were detected and any details regarding their growth.
A BLASTn analysis performed at the NCBI server (https://blast.ncbi.nlm.nih.gov/, accessed on 4 June 2025) with the genomic sequence of the P. sordellii isolate did not detect the genes encoding the lethal toxin (tcsL) or the hemorrhagic toxin (tcsH). However, the presence of plC (phospholipase C), sdL (sordellilysin), and nanS (sialidase) genes was confirmed, suggesting their potential involvement in the observed cytotoxicity [36].
  • Toxicological findings
Toxicological analyses were performed on biological samples (central and peripheral blood, urine, vitreous humor and bile) collected during the autopsy and rapidly stored at −20 °C. Cocaine, and its main metabolite (benzoylecgonine), methadone, and lorazepam were quantified as reported in Table 2. Blood alcohol content was negative.

4. Discussion

The case is worth reporting primarily because it was a case of sudden death that autopsy and histological examination ascribed to a fulminant shock syndrome, which the associated microbiological workup suggested to be caused by a P. sordellii infection. The patient was a known cocaine addict, although they smoked the drug rather than injecting it, which is more common in these cases of chronic drugs abusers. However, in this instance, there were no signs of injections, which was recently confirmed by the patient who openly admitted to smoking crack. This case also emphasizes the importance of post-mortem microbiological samplings in cases of sudden death or death without a witness.
Clostridium sordellii, first described by Alfredo Sordelli [37] under the name “bacillus oedematis sporogenes” [38] and later categorized as Paeniclostridium [1] and then as Paraclostridium [2], is an anaerobic, Gram-positive, spore-forming rod implicated in acute and severe infections in both humans and animals [39,40,41]. Like other clostridia, P. sordellii is commonly found in soil but can also be present in a small percentage of the population in the vagina or rectum [42], although this percentage may vary between populations [43].
While non-pathogenic strains of P. sordellii exist, there are others that produce two unique toxins that are significant virulence factors [44]: the lethal toxin (TcsL) and the hemorrhagic toxin (TcsH), both of which interfere with the Rho pathway [45] and bear similarities to toxins produced by Clostridioides difficile [46,47]. P. sordellii also produces other exotoxins whose role in pathogenesis has not been extensively studied [34].
The lethal toxin was shown to induce a massive increase in vascular permeability in mice [48]. In humans, it causes a peculiar toxic shock syndrome strictly related to capillary leaking. This syndrome is characterized by diffuse edema, unresponsive to treatment hypotension with hemoconcentration, sometimes gastrointestinal or nonspecific symptoms, massive leukocytosis (frequently more than 50,000 cells/microL, a value so high it is called a “leukemoid reaction” [49]), and absence of fever, due to the specific anti-inflammatory properties of TcsL [50].
P. sordellii may also cause a less specific clinical syndrome: myonecrosis with gas gangrene that shares many features with other clostridial infections [51]. Like many other pathogenic bacteria, it can also cause a less common localized infection without any remarkable traits that may eventually evolve into sepsis.
Infections caused by P. sordellii exhibit two typical characteristics: from a clinical perspective, the rapid onset of tissue necrosis and shock leading to multi-organ failure; from a pathophysiological mechanism perspective, there is a generalized capillary leak and a massive increase in circulating leukocytes, defined as a “leukemoid reaction.”
Each clinical syndrome seems to be more closely related to a specific mode of infection: while toxic shock syndrome is predominant in infections related to obstetrics and gynecological procedures, myonecrosis seems to be prevalent in post-traumatic and drug-related infections, as well as in subjects with immunosuppression. Localized infections do not show any remarkable pattern. The largest review reported by Aldape et al. [34] highlighted that out of a total of 45 cases, the majority were related to gynecological procedures, with 11% involving medically induced abortions, 0.4% related to spontaneous abortions, and 18% concerning normal deliveries. In all three mentioned categories, the observed mortality rate was 100%. Conversely, 22% of the cases were linked to the use of injectable drugs, and in this category, a significantly lower mortality rate of 50% was observed. A similar mortality rate of 53% was noted for infections resulting from trauma or surgical procedures, which accounted for 43% of the sample. Considering the sample as a whole, the mortality rate was found to be 69% (31 subjects out of 45), with approximately 85% of deaths occurring within less than a week (2–6 days) and in the presence of a leukemoid reaction. Overall, these data show that infections caused by P. sordellii, although rare, present extremely high mortality rates, approaching 100% in certain patient categories; therefore, it is essential to maintain a high level of awareness regarding this pathogen [52,53]. Table 3 provides a list from the case reports and case series identified in the literature and some summary notes regarding the content of each.
The authors present here a case of death in a female drug addict who was found dead in a park. The autopsy and subsequent histopathological examinations revealed findings consistent with acute heart failure due to sepsis syndrome, including morphonuclear lymphocyte infiltration intravascular in the heart and lungs with granulocytes, as well as the presence of Gram-positive bacilli in the same organs. Microbiological workup performed on autopsy specimens revealed the presence of P. sordellii in two separate blood samples, which was considered highly suggestive, in combination with the patient’s history and the anatomical and histopathological findings, with a case of fulminant shock syndrome associated with P. sordellii infection.
However, it should be noted that the blood cultures were also positive for various species of coagulase negative staphylococci (which are common skin colonizers), which might reflect the occurrence of contamination upon sampling, and that one vial was also positive for Enterococcus faecalis and Escherichia coli, which are normally members of the intestinal microbiota. The latter finding could reflect the fact that autopsy was performed 72 h after time of death, i.e., when post-mortem changes might have led to the permeabilization of the intestinal wall and subsequent migration of gastrointestinal bacteria to inner organs and blood. Therefore, we cannot exclude that the occurrence of P. sordellii in the blood could have been the result of a post-mortem scenario.
Moreover, in our case, numerous Gram-positive bacilli were observed in the heart by microscopy, but upon cultivation, a Gram-negative rod (namely a Citrobacter freundii) was detected. The latter finding could reflect the fact that culture conditions used for tissue specimens were different from those uses for blood specimens, and might have been no permissive for growth of P. sordellii.
Toxicological analysis revealed consumption of lorazepam, methadone, and cocaine at “therapeutic/normal” levels. Bile concentrations suggested recent consumption of cocaine and methadone, confirming a history of cocaine abuse and therapeutic use of opioids. None of the substances played a significant role in the cause of death.
The forensic diagnosis and conclusion are consistent with the information available from what is reported in the literature regarding findings from rare cases. P. sordellii infections are characterized by the absence or only mild local inflammatory response. Experimental infection with P. sordellii induces edema, muscle fiber disruption, tissue necrosis, and significant increase in white blood cells, specifically neutrophils, in vessels of all tissue specimens.
The infection can occur in subjects who use drugs, especially injectable ones, as in this case. Regardless of the cause of infection, P. sordellii cases are often apyrexial and develop a profound leukemoid reaction, as witnessed here. The case involves a sudden death suspected to be caused by an overdose, occurring without any prodromal symptoms or signs of infection in the 24 h leading up to death, linked to P. sordellii, a pathology that is often lethal but infrequently encountered.
This case highlights the importance of microbiological testing in cases of sudden and/or unwitnessed deaths. Despite the difficulties related to interpreting microbiological results, which represent a limitation of our findings, they underscore the importance of integrating these results with macroscopic investigations during the autopsy and histopathological results can help in discriminating between microbiological positivity from post-mortem bacterial translocation or contamination and positivity from local or systemic infection contracted in the pre-mortem period.

5. Conclusions

The case presented highlights the significance of conducting comprehensive microbiological investigations in cases of sudden death, even in the absence of clear signs of an active infection. It is important to carefully evaluate the results of these tests, as several factors can affect them. Therefore, it is crucial to combine microbiological findings with a thorough examination that takes into account both the macroscopic and microscopic evidence seen during the autopsy.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/pathogens14070703/s1, Table S1: Culture media and conditions used for microbiological analysis of autoptic specimens.

Author Contributions

Each author has made substantial contributions to the conception or design of this work, has approved the submitted version that involves author contributions to this study, and agrees to be personally accountable for their own contributions. Conceptualization, F.M. and G.M.R.; methodology, V.P. and F.M.; software, S.F.; validation, R.G., I.B. and F.V.; formal analysis, B.D.; investigation, S.F., N.C. and L.N.; resources, E.C. and M.F.; data curation, B.D.; writing—original draft preparation, S.F. and F.M.; writing—review and editing, G.M.R.; visualization, I.B.; supervision, V.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Acknowledgments

Genomic characterization of the strain was carried out by Marco Coppi, Microbiology and Virology Unit, Careggi University Hospital and Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Sasi Jyothsna, T.S.; Tushar, L.; Sasikala, C.; Ramana, C.V. Paraclostridium benzoelyticum gen. nov., sp. nov., isolated from marine sediment and reclassification of Clostridium bifermentans as Paraclostridium bifermentans comb. nov. Proposal of a new genus Paeniclostridium gen. nov. to accommodate Clostridium sordellii and Clostridium ghonii. Int. J. Syst. Evol. Microbiol. 2016, 66, 1268–1274, Erratum in Int. J. Syst. Evol. Microbiol. 2016. [Google Scholar] [CrossRef] [PubMed]
  2. Bello, S.; McQuay, S.; Rudra, B.; Gupta, R.S. Robust demarcation of the family Peptostreptococcaceae and its main genera based on phylogenomic studies and taxon-specific molecular markers. Int. J. Syst. Evol. Microbiol. 2024, 74, 006247. [Google Scholar] [CrossRef] [PubMed]
  3. Mory, F.; Lozniewski, A.; Guirlet, M.N.; Guidat, D.; Bresler, L.; Weber, M.; Boissel, P. Severe sepsis Caused by Clostridium sordellii Following Liver Biopsy in a Liver Transplant Recipient. Clin. Infect. Dis. 1995, 1, 1522–1523. [Google Scholar] [CrossRef] [PubMed]
  4. Cunniffe, J.G. Clostridium sordellii bacteraemia. J. Infect. 1996, 3, 127–129. [Google Scholar] [CrossRef] [PubMed]
  5. Abdulla, A.; Yee, L. The clinical spectrum of Clostridium sordellii bacteraemia: Two case reports and a review of the literature. J. Clin. Pathol. 2000, 53, 709–712. [Google Scholar] [CrossRef] [PubMed]
  6. Elsayed, S.; Zhang, K. Positive Clostridium difficile Stool Assay in a Patient with Fatal C. sordellii Infection. N. Engl. J. Med. 2006, 355, 1284–1285. [Google Scholar] [CrossRef] [PubMed]
  7. Matten, J.; Buechner, V.; Schwarz, R. A Rare Case of Clostridium sordellii Bacteremia in an Immunocompromised Patient. Infection 2009, 37, 368–369. [Google Scholar] [CrossRef] [PubMed]
  8. Smith, C.; Goslin, B. Clostridium sordellii Surgical Site Infection after Breast Mass Excision: Case Report. Surg. Infect. 2013, 14, 160–162. [Google Scholar] [CrossRef] [PubMed]
  9. Bonnecaze, A.K.; Stephens, S.E.E.; Miller, P.J. Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcoma. BMJ Case Rep. 2016, 2016, bcr2016215240. [Google Scholar] [CrossRef] [PubMed]
  10. Varley, C.D.; Rogers, L.M.; Dixon, B.R.; Bernard, S.C.; Lacy, D.B.; Sulpizio, E.; Aronoff, D.M.; Townes, J.M. Persistent bacteremia and psoas abscess caused by a lethal toxin-deficient Paeniclostridium sordellii. Anaerobe 2022, 75, 102520. [Google Scholar] [CrossRef] [PubMed]
  11. Fischer, M.; Bhatnagar, J.; Guarner, J.; Reagan, S.; Hacker, J.K.; Van Meter, S.H.; Poukens, V.; Whiteman, D.B.; Iton, A.; Cheung, M.; et al. Fatal Toxic Shock Syndrome Associated with Clostridium sordellii after Medical Abortion. N. Engl. J. Med. 2005, 353, 2352–2360. [Google Scholar] [CrossRef] [PubMed]
  12. McGregor, J.A.; Soper, D.E.; Lovell, G.; Todd, J.K. Maternal deaths associated with Clostridium sordellii infection. Am. J. Obstet. Gynecol. 1989, 161, 987–995. [Google Scholar] [CrossRef] [PubMed]
  13. Bitti, A.; Mastrantonio, P.; Spigaglia, P.; Urru, G.; Spano, A.I.; Moretti, G.; Cherchi, G.B. A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J. Clin. Pathol. 1996, 50, 259–260. [Google Scholar] [CrossRef] [PubMed]
  14. Sosolik, R.C.; Savage, B.A.; Vaccarello, L. Clostridium sordellii Toxic Shock Syndrome: A Case Report and Review of the Literature. Infect. Dis. Obstet. Gynecol. 1996, 4, 31–35. [Google Scholar] [CrossRef]
  15. Rørbye, C.; Petersen, I.S.; Nilas, L. Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome. Acta Obstet. Gynecol. Scand. 2000, 79, 1134–1135. [Google Scholar] [CrossRef] [PubMed]
  16. Sinave, C.; Le Templier, G.; Blouin, D.; Léveillé, F.; Deland, É. Toxic Shock Syndrome Due to Clostridium sordellii: A Dramatic Postpartum and Postabortion Disease. Clin. Infect. Dis. 2002, 35, 1441–1443. [Google Scholar] [CrossRef] [PubMed]
  17. Boyanton Jr, B.L.; Hanna, M.M.; Hafez-Khayyata, S.; Robinson-Dunn, B. Fatal Postpartum Infection. Infect. Dis. Clin. Pract. 2020, 28, 53–54. [Google Scholar] [CrossRef]
  18. Mattson, J.N.; Hardy-Fairbanks, A.J. Clostridium sordelli Toxic Shock After Endometrial Ablation: Review of Gynecologic Cases. J. Gynecol. Surg. 2018, 34, 311–314. [Google Scholar] [CrossRef]
  19. Elkbuli, A.; Diaz, B.; Ehrhardt, J.D.; Hai, S.; Kaufman, S.; McKenney, M.; Boneva, D. Survival from Clostridium toxic shock syndrome: Case report and review of the literature. Int. J. Surg. Case Rep. 2018, 50, 64–67. [Google Scholar] [CrossRef] [PubMed]
  20. Browdie, D.A.; Davis, J.H.; Koplewitz, M.J.; Corday, L.; Leadbetter, A.W. Clostridium Sordelli Infection. J. Trauma Acute Care Surg. 1975, 15, 515–518. [Google Scholar] [CrossRef] [PubMed]
  21. Grimwood, K.; Evans, G.A.; Govender, S.T.; Woods, D.E. Clostridium sordellii infection and toxin neutralization. Pediatr. Infect. Dis. J. 1990, 9, 582–585. [Google Scholar] [CrossRef] [PubMed]
  22. Gredlein, C.M.; Silverman, M.L.; Downey, M.S. Polymicrobial Septic Arthritis Due to Clostridium Species: Case Report and Review. Clin. Infect. Dis. 2000, 30, 590–594. [Google Scholar] [CrossRef] [PubMed]
  23. Bouvet, P.; Sautereau, J.; Le Coustumier, A.; Mory, F.; Bouchier, C.; Popoff, M.R. Foot Infection by Clostridium sordellii: Case Report and Review of 15 Cases in France. J. Clin. Microbiol. 2015, 53, 1423–1427. [Google Scholar] [CrossRef] [PubMed]
  24. Bogdan, J.C.; Rapkin, R.H. Clostridia infection in the newborn. Pediatrics 1976, 58, 120–122. [Google Scholar] [CrossRef] [PubMed]
  25. Gormley, D. Neonatal anaerobic (clostridial) cellulitis and omphalitis. Arch Dermatol. 1977, 113, 683–684. [Google Scholar] [CrossRef] [PubMed]
  26. Kosloske, A.M.; Bartow, S.A. Debridement of periumbilical necrotizing fasciitis: Importance of excision of the umbilical vessels and urachal remnant. J. Pediatr. Surg. 1991, 26, 808–810. [Google Scholar] [CrossRef] [PubMed]
  27. Adamkiewicz, T.V.; Goodman, D.; Burke, B.; Lyerly, D.M.; Goswitz, J.; Ferrieri, P. Neonatal Clostridium sordellii toxic omphalitis. Pediatr. Infect. Dis. J. 1993, 12, 253–257. [Google Scholar] [CrossRef] [PubMed]
  28. Rellinger, E.J.; Craig, B.T.; Craig-Owens, L.D.; Pacheco, M.C.; Chung, D.H.; Danko, M.E. Clostridium sordellii necrotizing omphalitis: A case report and literature review. J. Pediatr. Surg. Case Rep. 2016, 10, 35–38. [Google Scholar] [CrossRef]
  29. Brett, M.M.; Hood, J.; Brazier, J.S.; Duerden, B.I.; Hahné, S.J. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol. Infect. 2005, 133, 575–582. [Google Scholar] [CrossRef] [PubMed]
  30. Marinis, A.; Voultsos, M.; Grivas, P.; Dikeakos, P.; Liarmakopoulos, E.; Paschalidis, N.; Rizos, S. Vacuum-assisted therapy accelerates wound healing in necrotizing soft tissue infections: Our experience in two intravenous drug abuse patients. Infez. Med. 2013, 21, 305–311. [Google Scholar] [PubMed]
  31. Silva, J.; Henry, R.; Strickland, M.; Wang, D.; Matsushima, K. Rapidly fatal necrotizing soft tissue infection due to Clostridium sordellii in an injection drug user. Am. J. Emerg. Med. 2021, 44, 480.e1–480.e3. [Google Scholar] [CrossRef] [PubMed]
  32. Bangsberg, D.R.; Rosen, J.I.; Aragón, T.; Campbell, A.; Weir, L.; Perdreau-Remington, F. Clostridial Myonecrosis Cluster Among Injection Drug Users. Arch. Intern. Med. 2002, 162, 517–522. [Google Scholar] [CrossRef] [PubMed]
  33. Dunbar, N.M.; Harruff, R.C. Necrotizing Fasciitis: Manifestations, Microbiology and Connection with Black Tar Heroin. J. Forensic Sci. 2007, 52, 920–923. [Google Scholar] [CrossRef] [PubMed]
  34. Aldape, M.J.; Bryant, A.E.; Stevens, D.L. Clostridium sordellii Infection: Epidemiology, Clinical Findings, and Current Perspectives on Diagnosis and Treatment. Clin. Infect. Dis. 2006, 43, 1436–1446. [Google Scholar] [CrossRef] [PubMed]
  35. Meier-Kolthoff, J.P.; Göker, M. TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy. Nat. Commun. 2019, 10, 2182. [Google Scholar] [CrossRef] [PubMed]
  36. Awad, M.M.; Singleton, J.; Lyras, D. The Sialidase NanS Enhances Non-TcsL Mediated Cytotoxicity of Clostridium sordellii. Toxins 2016, 8, 189. [Google Scholar] [CrossRef] [PubMed]
  37. Stoppani, A.; Sordelli, D.O.; Méndez, B.S. Remembering a microbiologist: Alfredo Sordelli (1891–1967). Int. Microbiol. 2001, 4, 237–238. [Google Scholar] [CrossRef] [PubMed]
  38. Hall, I.C.; Scott, J.P. Bacillus Sordellii, a Cause of Malignant Edema in Man. J. Infect. Dis. 1927, 41, 329–335. [Google Scholar] [CrossRef]
  39. Junior, C.A.O.; Silva, R.O.S.; Lobato, F.C.F.; Navarro, M.A.; Uzal, F.A. Gas gangrene in mammals: A review. J. Vet. Diagn. Invest. 2020, 32, 175–183. [Google Scholar] [CrossRef] [PubMed]
  40. Uzal, F.A.; Navarro, M.A.; Asin, J.; Henderson, E.E. Clostridial Diseases of Horses: A Review. Vaccines 2022, 10, 318. [Google Scholar] [CrossRef] [PubMed]
  41. Gornatti-Churria, C.D.; Crispo, M.; Shivaprasad, H.L.; Uzal, F.A. Gangrenous dermatitis in chickens and turkeys. J. Vet. Diagn. Invest. 2018, 30, 188–196. [Google Scholar] [CrossRef] [PubMed]
  42. Chong, E.; Winikoff, B.; Charles, D.; Agnew, K.; Prentice, J.L.; Limbago, B.M.; Platais, I.; Louie, K.; Jones, H.E.; Shannon, C. Vaginal and Rectal Clostridium sordellii and Clostridium perfringens Presence Among Women in the United States. Obstet. Gynecol. 2016, 127, 360–368. [Google Scholar] [CrossRef] [PubMed]
  43. Ohashi, Y.; Fujisawa, T. Analysis of Clostridium cluster XI bacteria in human feces. Biosci. Microbiota Food Health 2019, 38, 65–68. [Google Scholar] [CrossRef] [PubMed]
  44. Vidor, C.; Awad, M.; Lyras, D. Antibiotic resistance, virulence factors and genetics of Clostridium sordellii. Res. Microbiol. 2015, 166, 368–374. [Google Scholar] [CrossRef] [PubMed]
  45. Jank, T.; Aktories, K. Structure and mode of action of clostridial glucosylating toxins: The ABCD model. Trends Microbiol. 2008, 16, 222–229. [Google Scholar] [CrossRef] [PubMed]
  46. Green, G.A.; Schué, V.; Monteil, H. Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: Homology with clostridium difficile cytotoxin B. Gene 1995, 161, 57–61. [Google Scholar] [CrossRef] [PubMed]
  47. Sirigi Reddy, A.R.; Girinathan, B.P.; Zapotocny, R.; Govind, R. Identification and Characterization of Clostridium sordellii Toxin Gene Regulator. J. Bacteriol. 2013, 195, 4246–4254. [Google Scholar] [CrossRef] [PubMed]
  48. Geny, B.; Khun, H.; Fitting, C.; Zarantonelli, L.; Mazuet, C.; Cayet, N.; Szatanik, M.; Prevost, M.C.; Cavaillon, J.M.; Huerre, M.; et al. Clostridium sordellii Lethal Toxin Kills Mice by Inducing a Major Increase in Lung Vascular Permeability. Am. J. Pathol. 2007, 170, 1003–1017. [Google Scholar] [CrossRef] [PubMed]
  49. Aronoff, D.M. Clostridium novyi, sordellii, and tetani: Mechanisms of disease. Anaerobe 2013, 24, 98–101. [Google Scholar] [CrossRef] [PubMed]
  50. Popoff, M.R. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response. Toxicon 2018, 149, 54–64. [Google Scholar] [CrossRef] [PubMed]
  51. Bryant, A.E.; Stevens, D.L. Clostridial Myonecrosis: New Insights in Pathogenesis and Management. Curr. Infect. Dis. Rep. 2010, 12, 383–391. [Google Scholar] [CrossRef] [PubMed]
  52. García, M.G.; Pérez-Cárceles, M.D.; Osuna, E.; Legaz, I. Impact of the Human Microbiome in Forensic Sciences: A Systematic Review. Appl. Environ. Microbiol. 2020, 86, e01451-20. [Google Scholar] [CrossRef] [PubMed]
  53. Schulz, M.; Schmoldt, A.; Andresen-Streichert, H.; Iwersen-Bergmann, S. Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit. Care 2020, 24, 195. [Google Scholar] [CrossRef] [PubMed]
  54. Thys, J.P.; Ectors, P.; Noel, P. Non-traumatic clostridial myositis: An unusual feature of brain death. Postgrad. Med. J. 1980, 56, 501–503. [Google Scholar] [CrossRef] [PubMed]
  55. Barnes, P.; Leedom, J.M. Infective endocarditis due to Clostridium sordellii. Am. J. Med. 1987, 83, 605. [Google Scholar] [CrossRef] [PubMed]
  56. Hogan, S.F.; Ireland, K. Fatal acute spontaneous endometritis resulting from Clostridium sordelli. Am. J. Clin. Pathol. 1989, 91, 104–106, Erratum in Am. J. Clin. Pathol. 1989, 92, 128. [Google Scholar] [CrossRef] [PubMed]
  57. Buchman, A.L.; Ponsillo, M.; Nagami, P.H. Empyema caused by Clostridium sordellii, a rare form of pleuropulmonary disease. J. Infect. 1991, 22, 171–174. [Google Scholar] [CrossRef] [PubMed]
  58. Spera, R.V.; Kaplan, M.H.; Allen, S.L. Clostridium sordellii Bacteremia: Case Report and Review. Clin. Infect. Dis. 1992, 15, 950–954. [Google Scholar] [CrossRef] [PubMed]
  59. Borer, A.; Gilad, J.; Sikuler, E.; Riesenberg, K.; Schlaeffer, F.; Buskila, D. Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J. Infect. 1999, 38, 128–129. [Google Scholar] [CrossRef] [PubMed]
  60. Cobo, F.; Aliaga, L.; Miranda, C.; de la Rosa, M. Clostridium sordelii corneal ulcer. Infection 2001, 29, 107–178. [Google Scholar] [CrossRef] [PubMed]
  61. Centers for Disease Control and Prevention (CDC). Update: Unexplained deaths following knee surgery—Minnesota, 2001. MMWR Morb. Mortal Wkly. Rep. 2001, 50, 1080. [Google Scholar]
  62. Lorea, P.; Baeten, Y.; Chahidi, N.; Franck, D.; Moermans, J.P. A severe complication of muscle transfer: Clostridial myonecrosis. Ann. Chir. Plast. Esthet. 2004, 49, 32–35. [Google Scholar] [CrossRef] [PubMed]
  63. Zink, J.M.; Singh-Parikshak, R.; Sugar, A.; Johnson, M.W. Clostridium sordellii Endophthalmitis After Suture Removal from a Corneal Transplant. Cornea 2004, 23, 522–523. [Google Scholar] [CrossRef] [PubMed]
  64. Wiebe, E.; Guilbert, E.; Jacot, F.; Shannon, C.; Winikoff, B. A Fatal Case of Clostridium sordellii Septic Shock Syndrome Associated with Medical Abortion. Obstet. Gynecol. 2004, 104 Pt 2, 1142–1144. [Google Scholar] [CrossRef] [PubMed]
  65. Cohen, A.L.; Bhatnagar, J.; Reagan, S.; Zane, S.B.; D'Angeli, M.A.; Fischer, M.; Killgore, G.; Kwan-Gett, T.S.; Blossom, D.B.; Shieh, W.J.; et al. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet. Gynecol. 2007, 192, 418–425. [Google Scholar] [CrossRef] [PubMed]
  66. Foroulis, C.N.; Gerogianni, I.; Kouritas, V.K.; Karestsi, E.; Klapsa, D.; Gourgoulianis, K.; Petinaki, E. Direct detection of Clostridium sordellii in pleural fluid of a patient with pneumonic empyema by a broad-range 16S rRNA PCR. Scand. J. Infect. Dis. 2007, 39, 617–619. [Google Scholar] [CrossRef] [PubMed]
  67. Ho, C.S.; Bhatnagar, J.; Cohen, A.L.; Hacker, J.K.; Zane, S.B.; Reagan, S.; Fischer, M.; Shieh, W.J.; Guarner, J.; Ahmad, S.; et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age. Am. J. Obstet. Gynecol. 2009, 353, 2352. [Google Scholar] [CrossRef] [PubMed]
  68. Valour, F.; Boisset, S.; Lebras, L.; Martha, B.; Boibieux, A.; Perpoint, T.; Chidiac, C.; Ferry, T.; Peyramond, D. Clostridium sordellii Brain Abscess Diagnosed by 16S rRNA Gene Sequencing. J. Clin. Microbiol. 2010, 48, 3443–3444. [Google Scholar] [CrossRef] [PubMed]
  69. Meites, E.; Zane, S.; Gould, C. Fata l Clostridium sordellii Infections after Medical Abortions. N. Engl. J. Med. 2010, 363, 1382–1383. [Google Scholar] [CrossRef] [PubMed]
  70. Chaudhry, R.; Verma, N.; Bahadur, T.; Chaudhary, P.; Sharma, P.; Sharma, N. Clostridium sordellii as a Cause of Constrictive Pericarditis with Pyopericardium and Tamponade. J. Clin. Microbiol. 2011, 49, 3700–3702. [Google Scholar] [CrossRef] [PubMed]
  71. Walk, S.T.; Jain, R.; Trivedi, I.; Grossman, S.; Newton, D.W.; Thelen, T.; Hao, Y.; Songer, J.G.; Carter, G.P.; Lyras, D.; et al. Non-toxigenic Clostridium sordellii: Clinical and microbiological features of a case of cholangitis-associated bacteremia. Anaerobe 2011, 17, 252–256. [Google Scholar] [CrossRef] [PubMed]
  72. Guzzetta, M.; Williamson, A.; Duong, S. Clostridium Sordellii as an Uncommon Cause of Fatal Toxic Shock Syndrome in a Postpartum 33-Year-Old Asian Woman, and the Need for Antepartum Screening for This Clostridia Species in the General Female Population. Lab. Med. 2016, 47, 251–254. [Google Scholar] [CrossRef] [PubMed]
  73. Gray, S.F.; Dieudonne, B.E. Clostridium sordelli causing malignant edema in a trauma patient: A case report and review of literature. Pan Afr. Med. J. 2018, 30, 118. [Google Scholar] [CrossRef] [PubMed]
  74. Chaudhry, R.; Bahadur, T.; Sagar, T.; Agrawal, S.K.; Arif, N.; Choudhary, S.K.; Verma, N. Infective Endocarditis Caused by C. sordellii: The First Case Report from India. J. Lab. Physicians 2021, 13, 74–76. [Google Scholar] [CrossRef] [PubMed]
  75. Milano, V.R.; Cabanilla, M.G. Under the Skin: A Case Series of Clostridium sordellii Necrotizing Soft Tissue Infections in Patients Who Inject Drugs. Cureus 2023, 15, e43870. [Google Scholar] [CrossRef] [PubMed]
  76. Jacques, L.; Kelly, B.; Soehl, J.; Wagar, M.; Rhoades, J.; Cowley, E.S.; Pryde, P.G.; Cutler, A.; Eschenbach, D. Peripartum Uterine Clostridial Myonecrosis: A Report of Two Fatal Cases. WMJ 2024, 123, 213–217. [Google Scholar] [PubMed]
  77. Kurth, L.; Johnston, W.; Black, K.; Doucet, J.; Weaver, J. Mortality in a Clostridium sordellii Case Series. J. Surg. Res. 2024, 304, 259–263. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Brain oedema and congestion.
Figure 1. Brain oedema and congestion.
Pathogens 14 00703 g001
Figure 2. Gram staining in heart.
Figure 2. Gram staining in heart.
Pathogens 14 00703 g002
Table 1. Each sample, which bacteria were detected and any details regarding their growth.
Table 1. Each sample, which bacteria were detected and any details regarding their growth.
BiospecimenMicrobesNote
HeartCitrobacter freundiiObtained after broth enrichment
BrainKlebsiella ornithinolyticaRare colonies
LiverLactobacillus rhamnosusObtained after broth enrichment
SpleenStaphylococcus epidermidisObtained after broth enrichment
Lactobacillus spp.
Right kidneyEnterococcus gallinarumRare colonies
* Obtained after broth enrichment
Escherichia coli *
Bacterioides fragilis *
Left kidneyLactobacillus rhamnosusObtained after broth enrichment
Lung: right anterior upper lobeVeillonella parvulaObtained after broth enrichment
Lung: right anterior medial lobe Lactobacillus rhamnosusObtained after broth enrichment
Lung: right anterior lower lobe Negative
Lung: left anterior upper lobe Lactobacillus rhamnosusDiscrete number of colonies
* Obtained after broth enrichment
Veillonella parvula
Enterococcus faecalis *
Lung: left anterior lower lobeEnteroccoccus faecalisObtained after broth enrichment
Blood 1st sampleStaphyloccoccus epidermidis§ obtained from anaerobic culture
Staphylococcus lugdunensis
Enterococcus faecalis
Escherichia coli
Paraclostridium sordellii §
Blood 2nd sampleStaphylococcus epidermidis§ obtained from anaerobic culture
Staphylococcus hominis
Paraclostridium sordellii §
UrineNegative
Rectal swabNegative
Nasopharyngeal swab SARS-CoV2Negative
* = Temperature of 35 °C (±1 °C) was used for incubation; § aerobic atmosphere enriched with 5% CO2 was used for incubation of CHOC plates; anaerobic atmosphere was obtained in dedicated sealed boxes using “AnaerogenTM Atmosphere generation system (ThermoScientific) pad, or in dedicated incubator for blood cultures (BactAlert system, Marcy l’Etoile, France, bioMérieux)”.
Table 2. Cocaine, benzoylecgonine, methadone, and lorazepam concentrations in biological samples.
Table 2. Cocaine, benzoylecgonine, methadone, and lorazepam concentrations in biological samples.
CompoundConcentrations (ng/mL)
Central BloodPeripheral BloodUrineVitreous HumorBile
Cocaine33292197296233735,847
Benzoylecgonine611012120125-
Methadone234515738132752
Lorazepam1211-<LOQ *31
* LOQ: limit of quantification (1 ng/mL).
Table 3. List from the case reports and case series identified in the literature.
Table 3. List from the case reports and case series identified in the literature.
AuthorsN° of Cases *Subject Age and SexType of CaseFatal
Outcome?
Autopsy
Performed?
How Was C.s. Diagnosed?Toxin Presence
Verified?
Browdie et al., 1975 [20]123 years MTraumatic
injury
yesyesCultural from woundno
Bogdan et al., 1976 [24]113 days FOmphalitisyesyesCultural from blood and fluid from the site of infection no
Gormley et al., 1977 [25]14 days FOmphalitisyesyesCultural from fluid from the site of infectionno
Thys et al., 1980 [54]118 years MOtheryes **yesIsolated from muscle and blood sampleno
Barnes et al., 1987 [55]161 years MOtherno--Cultural from blood samples and pleural fluidno
Hogan et al., 1989 [56]139 years FGynecological/obstetricianyesyesCultural from an exudate of myometrium acquired at autopsyno
McGregor et al., 1989 [12]328 years FGynecological/obstetricianyesyesCultural from “clot” from vagina no
23 years FGynecological/obstetricianyesnoCultural from cervical lesionno
23 years FGynecological/obstetricianyesyesCultural from intraoperative and autopsy samplesyes
Grimwood et al., 1990 [21]14 years FTraumatic injuryno--Cultural from necrotic tissue from the site of infectionyes
Kosloske et al., 1991 [26]19 days FOmphalitisno--Cultural from exudate and tissues from site of infectionno
Buchman et al., 1991 [57]195 years FOtherno ***noCultural from pleural fluidno
Spera J, et al., 1992 [58]137 years MDrug relatedno--Cultural from blood samplesno
Adamkiewicz et al., 1993 [27]117 days FOmphalitisyesyesCultural from peritoneal fluid and umbilical tissueyes
Mory et al., 1995 [3]148 years FImmunosuppressed/oncological patient yesyesCultural from blood samples and liver tissue acquired at autopsyyes
Bitti et al., 1996 [13]129 years FGynecological/obstetricianyesnoCultural from bloodyes
Cunnife et al., 1996 [4]155 years MImmunosuppressed/oncological patient yesyesCultural from blood and stool samplesyes
Sosolik et al., 1996 [14]124 years FGynecological/obstetricianyesyesCultural from resected necrotic tissueno
Borer et al., 1999 [59]173 years MImmunosuppressed/oncological patient yesyesCultural from blood samplesno
Gredlein et al., 2000 [22]137 years M Traumatic injuryno--Cultural from intraoperative samples from site of infection no
Rorbye et al., 2000 [15]140 years FGynecological/obstetricianyesnoCultural from discharge from site of infectionno
Abdulla et al., 2000 [5]281 years FOtheryesyesCultural from blood samplesno
12 years MImmunosuppressed/oncological patient no--Cultural from blood samplesno
Cobo et al., 2001 [60]117 years FOtherno--Cultural from a corneal ulcerno
CDC* 2001 [61]123 years MOtheryesyesCultural from bloodno
Bangsberg et al., 2002 [32]228 years FDrug relatedyesnoCultural from surgical woundno
52 years MDrug relatedno--Cultural from intraoperative sample of tissues from site of infectionno
Sinave et al., 2002 [16]126 years FGynecological/obstetricianyesyesCultural from endometrial biopsyno
Lorea et al., 2004 [62]149 years MOtherno--Cultural from perioperative samplesno
Zink et al., 2004 [63]133 years MOtherno--Cultural from vitreous sampleno
Wiebe et al.,
2004 [64]
127 years FGynecological/obstetricianyesyesCultural from endometrial biopsy and perioperative samplesno
Fischer et al., 2005 [11]418 years FGynecological/obstetricianyesyesPCR assay from DNA extracted from uterine tissues fixed in formalinyes
21 years FGynecological/obstetricianyesyesPCR assay from DNA extracted from uterine tissues fixed in formalinyes
22 years FGynecological/obstetricianyesyesPCR assay from DNA extracted from uterine tissues fixed in formalinyes
34 years FGynecological/obstetricianyesyesPCR assay from DNA extracted from uterine tissues fixed in formalinyes
Brett et al., 2005 [29]1unknown MDrug relatedyesnonot specifiedno
Aldape et al., 2006 [34]24 years MTraumatic injuryyesyesCultural from intraoperative samples from site of infectionno
21 years FGynecological/obstetricianyesyesCultural from intraoperative samples from site of infectionno
Elsayed et al., 2006 [6]161 years FImmunosuppressed/oncological patient yesyesCultural from blood samplesyes
Cohen et al., 2007 [65]225 years FGynecological/obstetricianno--Cultural from blood and cervical samplesyes
18 years FGynecological/obstetricianyesyesImmunohistochemical and PCR assay on uterine tissueyes
Matten et al., 2009 [7]159 years MImmunosuppressed/oncological patient no--Cultural from blood samples and from pleural and liver drainageyes
Foroulis et al., 2009 [66]156 years MOtherno--PCR analysis from pleural fluidyes
Ho et al., 2009 [67]232 years FGynecological/obstetricianyesyesImmunohistochemical and PCR assay on fixed tissueyes
40 years FGynecological/obstetricianyesyesImmunohistochemical and PCR assay on fixed tissueyes
Valour et al., 2010 [68]131 years FTraumatic injuryno--PCR analysis on DNA from infected brain tissueyes
Meites et al., 2010 [69]229 years FGynecological/obstetricianyesnoPCR assay from infected tissueno
21 years FGynecological/obstetricianyesnoPCR assay from infected tissueno
Chaudhry et al., 2011 [70]18 months MOtherno--Cultural and PCR assay from intraoperative samples yes
Walk et al., 2011 [71]181 years FOtherno--Cultures from blood samples and PCR assay on the cultured strainsyes
Smith et al., 2013 [8]137 years FImmunosuppressed/oncological patient no--Cultural from samples from site of infectionno
Marinis et al., 2013 [30]125 years FDrug relatedno--Cultural from intraoperative samples from site of infectionno
Bouvet et al., 2015 [23]178 years MTraumatic injurynot specifiednoCultural from blood and PCR assay on subcultureyes
Guzzetta et al., 2016 [72]133 years FGynecological/obstetricianyesyesCultural from episiotomy site and blood samplesno
Rellinger et al., 2016 [28]18 days MOmphalitisyesyesCultural from intraoperative samples of tissues from site of infectionno
Bonnecaze et al., 2016 [9]167 years FImmunosuppressed/oncological patient no--Cultural from blood samplesno
Gray et al., 2018 [73]161 years MTraumatic injurynot specified--Cultural from wound siteno
Mattson et al., 2018 [18]145 years FGynecological/obstetricianno--Cultural from intraoperative sample from site of infectionno
Elkubuli et al., 2018 [19]131 years FGynecological/obstetricianno--Immunohistochemical and PCR assay on intraoperative samplesno
Boyanton et al., 2019 [17]129 years FGynecological/obstetricianyesnoCultural from ascites samplesno
Silva et al., 2020 [31]137 years FDrug relatedyesnoCultural from intraoperative samples from site of infectionno
Chaudhry et al., 2021 [74]128 years FOtherno--Cultural from intraoperative samples from site of infectionyes
Varley et al., 2022 [10]163 years MImmunosuppressed/oncological patient no--Cultural from blood samplesyes
Milano et al.,
2023 [75]
434 years
M
Lupus/drug relatedyesnoCultural from intraoperative samples from site of infectionyes
41 years
M
Drug relatedno--Cultural from intraoperative samples from site of infectionyes
42 years
M
Morbid obesity/drug relatedyesyesCultural from abdominal wall tissue yes
47 years
M
Drug relatedyesnoCultural from intraoperative samples from site of infectionyes
Jacques et al.,
2024 [76]
230 years
F
42 weeks gestationyesyesUterine and placental cultures yes
Cultural from blood samplesno
Adolescence
F
Medication abortionyesyesEndometrial cultureyes
Kurth et al.,
2024 [77]
1530Drug relatedno--Cultural from intraoperative samples from site of infectionyes
69Drug relatedyesnoCultural from intraoperative samples from site of infectionyes
33Drug relatedno--Cultural from intraoperative samples from site of infectionyes
68/no--Cultural from intraoperative samples from site of infectionyes
58/no--Cultural from intraoperative samples from site of infectionyes
76/no--Cultural from intraoperative samples from site of infectionyes
50/no--Cultural from intraoperative samples from site of infectionyes
53Drug relatedno--Cultural from intraoperative samples from site of infectionyes
64/no--Cultural from blood samplesyes
42Drug relatedyesnoCultural from intraoperative samples from site of infectionyes
54/no--Cultural from blood samplesyes
60Drug relatedno--Cultural from intraoperative samples from site of infectionyes
47Drug relatedyesnoCultural from intraoperative samples from site of infectionyes
57Drug relatedyesnoCultural from intraoperative samples from site of infectionyes
80/yesnoCultural from blood samplesyes
* In some cases, death reports due to other Clostridia were presented but had not been counted in the table. ** Brain death of the subject had been already declared; the infection led to cardiac arrest. *** Patient survived the infection but died of unknown causes after a prolonged hospitalization; / Not drug related.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Focardi, M.; Faccioli, S.; Defraia, B.; Grifoni, R.; Bianchi, I.; Vaiano, F.; Novelli, L.; Ciccone, N.; Capasso, E.; Malentacchi, F.; et al. Fatal Paraclostridium sordellii Infection: Post-Mortem Assessment and Review of the Literature. Pathogens 2025, 14, 703. https://doi.org/10.3390/pathogens14070703

AMA Style

Focardi M, Faccioli S, Defraia B, Grifoni R, Bianchi I, Vaiano F, Novelli L, Ciccone N, Capasso E, Malentacchi F, et al. Fatal Paraclostridium sordellii Infection: Post-Mortem Assessment and Review of the Literature. Pathogens. 2025; 14(7):703. https://doi.org/10.3390/pathogens14070703

Chicago/Turabian Style

Focardi, Martina, Simone Faccioli, Beatrice Defraia, Rossella Grifoni, Ilenia Bianchi, Fabio Vaiano, Luca Novelli, Nunziata Ciccone, Emanuele Capasso, Francesca Malentacchi, and et al. 2025. "Fatal Paraclostridium sordellii Infection: Post-Mortem Assessment and Review of the Literature" Pathogens 14, no. 7: 703. https://doi.org/10.3390/pathogens14070703

APA Style

Focardi, M., Faccioli, S., Defraia, B., Grifoni, R., Bianchi, I., Vaiano, F., Novelli, L., Ciccone, N., Capasso, E., Malentacchi, F., Pinchi, V., & Rossolini, G. M. (2025). Fatal Paraclostridium sordellii Infection: Post-Mortem Assessment and Review of the Literature. Pathogens, 14(7), 703. https://doi.org/10.3390/pathogens14070703

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop